News & Updates

Show Multimedia Only

Probiotics may help in the fight against COVID-19

15 Apr 2024 by

Post-exposure prophylaxis with the probiotic Lacticaseibacillus rhamnosus GG (LGG) led to prolonged time to COVID-19 infection, reduced incidence of symptoms, and gut microbiome changes, but not overall incidence, a study suggests.

15 Apr 2024

Growing incidence of HPV-positive oropharyngeal cancer in HK

09 Apr 2024 by

A retrospective study by the Chinese University of Hong Kong (CUHK) reports a growing incidence of oropharyngeal cancer, with an increasing proportion of human papillomavirus (HPV)–positive cases in Hong Kong in recent years.

09 Apr 2024

2 drugs in 1 pill better than complex regimens for HIV

09 Apr 2024 by

The combination of bictegravir and lenacapavir, taken orally once daily, performed better than current complex treatment regimens in the phase II ARTISTRY-1 trial of people with HIV who are virologically suppressed.

09 Apr 2024

$TDF ups fracture risk in older patients with chronic hepatitis B$

TDF ups fracture risk in older patients with chronic hepatitis B

05 Apr 2024 by

Tenofovir disoproxil fumarate (TDF) is associated with a higher fracture risk vs entecavir (ETV) after 2 years of treatment in older patients with chronic hepatitis B (CHB), a territory-wide cohort study has shown.

05 Apr 2024

H pylori eradication boosts survival outcomes for gastric cancer patients

03 Apr 2024

In gastric cancer patients with Helicobacter pylori infection, eradicating the infection leads to improved survival rates, as shown in a study.

03 Apr 2024

COVID vaccine hesitancy linked to traffic crashes

01 Apr 2024

People who refused to be vaccinated against COVID-19 appear to be at significantly greater risks of a traffic accident, reports a study.

01 Apr 2024

Long-term TAF tied to high viral suppression in CHB

27 Mar 2024 by

Patients with chronic hepatitis B (CHB) who has undergone long-term treatment with tenofovir alafenamide (TAF) achieve high rates of viral suppression comparable to those of tenofovir disoproxil fumarate (TDF; or TDF switched to TAF) with favourable renal and bone safety, results of a study have shown.

27 Mar 2024

Intramuscular injection preferable to IV infusion of ibalizumab for PWH

22 Mar 2024 by

Ibalizumab delivered via intramuscular (IM) injection is not only safe and well-tolerated but also succeeds in viral suppression among heavily treatment experienced (HTE) people living with HIV (PWH), making IM the preferred method of administration among participants of the TMB-302 study.

22 Mar 2024

Bulevirtide works well against chronic hepatitis D, HIV/HBV/HDV coinfection

21 Mar 2024 by

Patients with hepatitis delta virus (HDV) show increased virologic and biochemical responses with longer bulevirtide (BLV) treatment for over 96 weeks, with no new safety concerns, as shown in a study presented at CROI 2024.

21 Mar 2024

COVID-19 rebound common following treatment with either VV116 or nirmatrelvir-ritonavir

20 Mar 2024

Among patients with mild-to-moderate COVID-19, viral rebound and symptom rebound occur frequently following a standard 5-day course of treatment with either VV116 or nirmatrelvir-ritonavir, as shown in a study from China.